These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 33233641)
1. Diagnostic and Therapeutic Implications of microRNAs in Non-Small Cell Lung Cancer. Ahn YH; Ko YH Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233641 [TBL] [Abstract][Full Text] [Related]
2. Clinical implication of microrna for lung cancer. Wang Y; Zhang X; Liu L; Li H; Yu J; Wang C; Ren X Cancer Biother Radiopharm; 2013 May; 28(4):261-7. PubMed ID: 23496233 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis. Lu C; Shan Z; Hong J; Yang L Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966 [TBL] [Abstract][Full Text] [Related]
4. Circulating microRNA-590-5p functions as a liquid biopsy marker in non-small cell lung cancer. Khandelwal A; Seam RK; Gupta M; Rana MK; Prakash H; Vasquez KM; Jain A Cancer Sci; 2020 Mar; 111(3):826-839. PubMed ID: 31520555 [TBL] [Abstract][Full Text] [Related]
5. microRNA-935 is reduced in non-small cell lung cancer tissue, is linked to poor outcome, and acts on signal transduction mediator E2F7 and the AKT pathway. Wang C; Li S; Xu J; Niu W; Li S Br J Biomed Sci; 2019 Jan; 76(1):17-23. PubMed ID: 30203720 [TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA PRNCR1 modulates non-small cell lung cancer cell proliferation, apoptosis, migration, invasion, and EMT through PRNCR1/miR-126-5p/MTDH axis. Guo R; Hu T; Liu Y; He Y; Cao Y Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 31912882 [TBL] [Abstract][Full Text] [Related]
7. microRNA-100 functions as a tumor suppressor in non-small cell lung cancer via regulating epithelial-mesenchymal transition and Wnt/β-catenin by targeting HOXA1. Han W; Ren X; Yang Y; Li H; Zhao L; Lin Z Thorac Cancer; 2020 Jun; 11(6):1679-1688. PubMed ID: 32364673 [TBL] [Abstract][Full Text] [Related]
8. microRNA and Lung Cancer. Del Vescovo V; Denti MA Adv Exp Med Biol; 2015; 889():153-77. PubMed ID: 26659001 [TBL] [Abstract][Full Text] [Related]
9. Tumor-suppressive effects of microRNA-181d-5p on non-small-cell lung cancer through the CDKN3-mediated Akt signaling pathway in vivo and in vitro. Gao LM; Zheng Y; Wang P; Zheng L; Zhang WL; Di Y; Chen LL; Yin XB; Tian Q; Shi SS; Xu SF Am J Physiol Lung Cell Mol Physiol; 2019 May; 316(5):L918-L933. PubMed ID: 30628487 [TBL] [Abstract][Full Text] [Related]
10. MicroRNAs: Emerging oncogenic and tumor-suppressive regulators, biomarkers and therapeutic targets in lung cancer. Tang S; Li S; Liu T; He Y; Hu H; Zhu Y; Tang S; Zhou H Cancer Lett; 2021 Apr; 502():71-83. PubMed ID: 33453304 [TBL] [Abstract][Full Text] [Related]
11. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC. Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155 [No Abstract] [Full Text] [Related]
12. MiR-7-5p suppresses tumor metastasis of non-small cell lung cancer by targeting NOVA2. Xiao H Cell Mol Biol Lett; 2019; 24():60. PubMed ID: 31832068 [TBL] [Abstract][Full Text] [Related]
13. Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer. Wang L; Tong X; Zhou Z; Wang S; Lei Z; Zhang T; Liu Z; Zeng Y; Li C; Zhao J; Su Z; Zhang C; Liu X; Xu G; Zhang HT Mol Cancer; 2018 Sep; 17(1):140. PubMed ID: 30261900 [TBL] [Abstract][Full Text] [Related]
14. The microRNA-200 family targets multiple non-small cell lung cancer prognostic markers in H1299 cells and BEAS-2B cells. Pacurari M; Addison JB; Bondalapati N; Wan YW; Luo D; Qian Y; Castranova V; Ivanov AV; Guo NL Int J Oncol; 2013 Aug; 43(2):548-60. PubMed ID: 23708087 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-422a functions as a tumor suppressor in non-small cell lung cancer through SULF2-mediated TGF-β/SMAD signaling pathway. Li WQ; Zhang JP; Wang YY; Li XZ; Sun L Cell Cycle; 2019 Aug; 18(15):1727-1744. PubMed ID: 31204561 [TBL] [Abstract][Full Text] [Related]
16. microRNA-548l is involved in the migration and invasion of non-small cell lung cancer by targeting the AKT1 signaling pathway. Liu C; Yang H; Xu Z; Li D; Zhou M; Xiao K; Shi Z; Zhu L; Yang L; Zhou R J Cancer Res Clin Oncol; 2015 Mar; 141(3):431-41. PubMed ID: 25245053 [TBL] [Abstract][Full Text] [Related]
17. MCRS1 overexpression, which is specifically inhibited by miR-129*, promotes the epithelial-mesenchymal transition and metastasis in non-small cell lung cancer. Liu MX; Zhou KC; Cao Y Mol Cancer; 2014 Nov; 13():245. PubMed ID: 25373388 [TBL] [Abstract][Full Text] [Related]
18. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer. Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799 [TBL] [Abstract][Full Text] [Related]
19. miR-638 is a new biomarker for outcome prediction of non-small cell lung cancer patients receiving chemotherapy. Wang F; Lou JF; Cao Y; Shi XH; Wang P; Xu J; Xie EF; Xu T; Sun RH; Rao JY; Huang PW; Pan SY; Wang H Exp Mol Med; 2015 May; 47(5):e162. PubMed ID: 25952770 [TBL] [Abstract][Full Text] [Related]
20. miR-942 promotes tumor migration, invasion, and angiogenesis by regulating EMT via BARX2 in non-small-cell lung cancer. Yang F; Shao C; Wei K; Jing X; Qin Z; Shi Y; Shu Y; Shen H J Cell Physiol; 2019 Dec; 234(12):23596-23607. PubMed ID: 31236953 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]